older glp 1 drugs How GLP-1 medications are transforming diabetes and weight loss treatment GLP-1 Agonists: A Comprehensive Overview
Description
Some fiber-rich foods include: Fruits (pears, raspberries, blueberries, etc.) Legumes (pinto beans, lentils, split peas, etc.) Nuts (almonds, pistachios, pine nuts, etc.) Seeds (flaxseeds, chia seeds, pumpkin seeds, etc.) Vegetables (squash, green peas, broccoli, etc.) Whole grains (quinoa, oatmeal, brown rice, etc.) Keep in mind that dietary fiber isnt found in animal productsits only found in plant-based foods

Preclinical studies have identified that GLP-1 analogs such as exendin-4 and GLP-1RAs have direct anti-atherosclerotic and anti-inflammatory effects that may contribute to their cardio- and neuroprotective nature.[42] GLP-1RAs can also directly interact with cardiomyocytes, inducing receptor-mediated ischemic conditioning that decreases myocardial infarct size in test animals receiving GLP-1RAs.[43] Similar effects were noted in rodent brains, with liraglutide reducing cerebral infarct volume in rats.[42] Randomized clinical trials (RCTs) also identified that exenatide similarly reduced myocardial infarct size and liraglutide reduced the resulting necrotic area in human patients following a MI.[43] This may account for the reduced need for coronary revascularization in patients on GLP-1RAs.[12] Despite the findings of overall improvements to composite cardiovascular outcomes, GLP-1RAs showed a non-significant trend toward reducing MI risk and did not affect rates of hospitalization for unstable angina in patients with diabetes.[12] These agents tend to have a stronger effect on stroke reduction in such patients, highlighting the complexity and variability of cardiovascular disease and its sequelae

Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, openlabel, phase 3b trial

doi:10.1016/j.diabet.2015.02.006 61

Nourish, pace the ramp, and use evidence-based scalp support

[DOI] [PubMed] [Google Scholar] 784.Tan T., Behary P., Tharakan G., Minnion J., Al-Najim W., Albrechtsen N.J.W
